Leah Sherwood

Featured in: Favicon

britannica.com Favicon

hawaii.edu Favicon

e-ir.info

auntminnie.com Favicon

drbicuspid.com Favicon

scienceboard.net Favicon

qoshe.com

auntminnieeurope.com Favicon

labpulse.com Favicon

bloodcancerstoday.com

Articles

Sunbird Bio shares new data on blood-based Parkinsonâ€™s diagnostic

Nov 1, 2024 | labpulse.com | Liz Carey |Matt Limb |Elissa Wolfson |Leah Sherwood

Biotech firm Sunbird Bio announced new data from a study demonstrating that Sunbird's technology could provide blood-based diagnosis of Parkinson's disease and other neurodegenerative diseases with a high level of accuracy. The results were shared on October 31 in a poster presentation at the Clinical Trials on Alzheimer's Disease 2024 international conference in Madrid, the company said in a statement.
NowDiagnostics at-home syphilis test gets boost from Labcorp agreement

Oct 10, 2024 | labpulse.com | Leah Sherwood |Bruce Carlson

Labcorp will expand its portfolio of sexually transmitted infection (STI) testing options as exclusive nationwide distributor of NowDiagnostics' First to Know Syphilis Test, a rapid at-home screening blood test. The U.S. Food and Drug Administration (FDA) granted marketing authorization August 16 for the qualitative rapid membrane immunochromatographic assay designed to detect Treponema (T.) pallidum (syphilis) antibodies.
Cepheid partners with Fleming Initiative on antimicrobial resistance

Sep 26, 2024 | labpulse.com | Matt Limb |Leah Sherwood

Diagnostics firm Cepheid has entered a partnership with the Fleming Initiative, a global collaboration that has been established by the Imperial College Healthcare National Health Service Trust and Imperial College London to combat antimicrobial resistance (AMR). The Fleming Initiative and Cepheid will introduce the partnership at an event in New York aligned with the United Nations General Assembly High-Level Meeting about AMR.
Seegene, Springer Nature launch PCR innovation program

Sep 3, 2024 | labpulse.com | Matt Limb |Nick Paul Taylor |Leah Sherwood

Molecular diagnostics firm Seegene and Springer Nature have launched "Nature Awards MDx Impact Grants in partnership with Seegene," a new project for the development of diagnostic assays, as part of their ongoing strategic partnership. The program aims to empower researchers to develop innovative diagnostic assays using Seegene's advanced multiplex polymerase chain reaction (PCR) technology, the partners said in a statement.
Leuko receives $4.5M SBIR grant for blood monitoring device

Jul 24, 2024 | labpulse.com | Matt Limb |Leah Sherwood |Joseph Constance

Medtech firm Leuko has received a $4.5 million Small Business Innovative Research phase IIB award from the U.S. National Institutes of Health National Cancer Institute to advance the development of PointCheck, its noninvasive at-home white blood cell monitoring device. White blood cell monitoring is critical to detect and avert infections, particularly for cancer patients receiving chemotherapy and other treatments that lead to a compromised immune system.
Tiba Biotech awarded BARDA contract for influenza therapeutics

Jul 12, 2024 | labpulse.com | Matt Limb |Nick Paul Taylor |Leah Sherwood

Tiba Biotech announced that it has been awarded an Easy Broad Agency Announcement R&D contract through the Biomedical Advanced Research and Development Authority (BARDA) to develop therapeutics against influenza.
GMU researchers receive $1.2M in funding for Lyme disease urine test

May 24, 2024 | labpulse.com | Matt Limb |Nick Paul Taylor |Leah Sherwood

Researchers at George Mason University (GMU) have received $1.2 million in federal funding from the U.S. Department of the Army to develop a urine-based test for the detection and diagnosis of Lyme disease.
Nanopath awarded $4M in SBIR grants

May 22, 2024 | labpulse.com | Matt Limb |Leah Sherwood |Joseph Constance

Nanopath has announced that it has been awarded two grants worth a total of $4 million in federal funding through the Small Business Innovation Research (SBIR) program. The Cambridge, MA-based molecular diagnostics firm was awarded a $3 million grant from the U.S. National Institutes of Health (NIH) and a $1 million grant from the National Science Foundation (NSF) to support further research and development of the company's point-of-care diagnostic platform for pelvic and gynecologic infections.
GSK, Genomics PLC collaborate on polygenic risk score use for clinical trials

May 1, 2024 | labpulse.com | Matt Limb |Leah Sherwood

Genomics PLC and biopharmaceutical firm GSK have established a collaboration aimed at assessing the potential for using polygenic risk scores (PRS) in clinical trials, with the ultimate goal of gaining an improved understanding of disease risk and optimizing trial design.
BMI not linked to worse jaw surgery outcomes, problems

Apr 16, 2024 | drbicuspid.com | Karie Neeley Anderson |Melissa Busch |Alex Dagostino |Leah Sherwood

Having a higher body mass index (BMI) may not correlate with poorerjaw surgery outcomes or postoperative complications. This research was recently published in the Journal of Oral and Maxillofacial Surgery. The study suggests that orthognathic surgery may be suitable for patients with elevated BMIs, a population that has traditionally been considered at greater risk of negative outcomes and perioperative complications, the authors wrote.